
    
      This is a randomized, placebo-controlled, double-blind study of healthy term infants,
      consisting of three randomized arms: placebo control group, high dose experimental group, and
      low dose experimental group. The study population, approximately 228, are infants 14 - 21
      days of age who are formula-fed and/or breastfed who is aligned with the intended target
      population for a probiotic supplement. Placebo and probiotic supplements will be mixed with
      formula or breastmilk and fed orally using a feeding cup or syringe. All enrolled infants
      will participate in the trial for approximately 8 weeks.
    
  